Burcon to pursue regulatory recognition for Puratein(R) and Supertein(TM)



    VANCOUVER, June 19 /CNW/ - Burcon NutraScience Corporation (TSX-V: BU) a
pioneer in the development of food-grade canola proteins, announces that, in
conjunction with its license and development partner, Archer Daniels Midland
("ADM"), an agricultural processor, it is proceeding to pursue regulatory
recognition for Puratein(R) and Supertein(TM) and has amended the license and
development agreement to expedite the process.
    Puratein(R) and Supertein(TM) are expected to participate with soy,
dairy, and egg proteins in the expanding multi-billion-dollar protein
ingredient market, with potential uses in prepared foods, nutritional
supplements, and personal care products.
    Canola protein does not form a part of the traditional North American
human diet and as such certain scientific studies including toxicology
assessments - such as feeding trials - will be undertaken by third-party
contract research organizations. It is currently projected that the required
scientific studies will be initiated within the next quarter.
    The scientific studies to be undertaken will support a U.S. GRAS
affirmation process and will be completed to standards that will also allow
their use in making application for regulatory approval under the Novel Foods
process in the European Community as well as in other countries such as
Canada.
    With the intention of expediting the regulatory approval process, Burcon
and ADM have agreed to amend the license and development agreement dated
September 16, 2003 made among Burcon NutraScience Corporation, Burcon
NutraScience (MB) Corp. and ADM (the "License and Development Agreement").
Under the terms of the amendment, there is now a defined cost sharing
structure for all of the third-party expenses incurred in the regulatory
recognition process. The amendment provides that either ADM or Burcon will
reimburse the other on the occurrence of certain events. If ADM chooses not to
proceed with the license under the License and Development Agreement and
terminates it in accordance with specific provisions under the agreement, then
Burcon will reimburse ADM for its share of the costs incurred in the
regulatory recognition process. Alternatively, if ADM chooses to proceed with
the license then ADM will reimburse Burcon for all of its costs incurred in
the regulatory recognition process. The total cost of the regulatory process
is currently estimated at US$1.1 million.
    "This is a major step on the path to commercializing the world's first
food-grade canola proteins," stated Johann F. Tergesen, Burcon's President &
COO who added, "We look forward to establishing that Puratein(R) and
Supertein(TM) are safe food ingredients. Together, we continue to advance what
we believe is an exciting and environmentally sustainable new protein source."

    For more information view our new website at www.burcon.ca

    About Burcon NutraScience
    Burcon is a research and development company developing a portfolio of
composition, application, and process patents around its plant protein
extraction and purification technology. The goal of Burcon's research is to
develop its patented process to utilize inexpensive oilseed meals for the
production of purified plant proteins that exhibit valuable nutritional,
functional or nutraceutical profiles. Burcon, in conjunction with Archer
Daniels Midland, is currently focusing its efforts on developing the world's
first commercial canola proteins, Puratein(R) and Supertein(TM). Canola,
recognized for its nutritional qualities, is the second-largest oilseed crop
in the world after soybeans. Burcon's goal is to develop Puratein(R) and
Supertein(TM) to participate with soy, dairy, and egg proteins in the
expanding multi-billion-dollar protein ingredient market, with potential uses
in prepared foods, nutritional supplements, and personal care products.

    ON BEHALF OF THE BOARD OF DIRECTORS
    "Johann F. Tergesen"
    Johann F. Tergesen
    President & Chief Operating Officer

    The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information contained
herein. This press release contains forward-looking statements that involve
risks and uncertainties. These forward-looking statements relate to, among
other things, plans and timing for the introduction or enhancement of our
products ,statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in this
press release that are not historical fact. Our expectations regarding the
prospect for future success depend upon our ability to develop and sell
products, which we do not produce today and cannot be sold without further
research and development. When used in this press release, the words
"goal,""intend," "believes" and "potential" and similar expressions,,generally
identify forward-looking statements. These statements reflect our current
expectations. They are subject to a number of risks and uncertainties. In
light of the many risks and uncertainties surrounding the development of a
source of protein from canola meal, you should understand that we cannot
assure you that the forward looking statements contained in this press release
will be realized.





For further information:

For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, (604) 733-0896, (888) 408-7960 toll-free,
jcheng@burcon.ca www.burcon.ca; AXINO AG, Sven Olsson, Investor Relations,
Europe Silberburgstrasse, 112, D-70176, Stuttgart, Germany, Tel. +49-711-25 35
92-30, Fax +49-711-25 35 92-33, olsson@axino.de, www.burcon.net; London, UK,
Archie Adams, Corporate Development, Burcon NutraScience Corporation, M. +44
(0) 7768 774311, T. +44 (0) 1235 524959, archie.adams@burcon.ca

Organization Profile

Burcon NutraScience Corporation

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890